European Approval of Experimental COVID-19 Replicon mRNA Injections is a Grave Mistake

Bacteria-mediated oral delivery of viral replicon-based mRNA vaccines

Last week, CSL and Arcturus Therapeutics announced that the European Commission has approved KOSTAIVE® (ARCT-154), a COVID-19 self-amplifying (replicon) mRNA injection, for individuals 18 and older.

It is the first replicon shot approved by the European Commission and is already being used in Japan.

These products behave like a synthetic virus. The replicon mRNA is designed to encode not only the target antigen but also viral replicase, enabling the mRNA to replicate itself within the target cells. This replication machinery allows for an unknown period of toxic antigen production:

A few months ago, I warned that the “European Commission must make the right decision and REJECT authorization for an experimental injection with a 90% adverse event rate and non existent long-term safety data.”

COVID-19 Self-Amplifying mRNA Injection Nears European Approval

·
December 14, 2024
COVID-19 Self-Amplifying mRNA Injection Nears European Approval

By Nicolas Hulscher, MPH

During the clinical trials for KOSTAIVE (ARCT-154), 90% of injected participants experienced adverse events, with 74.5% reporting systemic reactions and 15.2% requiring medical attention after the first dose:

The Biopharmaceutical Complex is preparing for the large-scale deployment of replicon mRNA injections, with least 33 candidates in development:

You can learn more about the ongoing self-amplifying mRNA assault in the following article I wrote back in November:

Attack of the Replicons

·
November 8, 2024
Attack of the Replicons

By Nicolas Hulscher, MPH

It’s become abundantly clear that the pharmaceutical industry and captured regulatory agencies have zero regard for the massive safety concerns of undefined synthetic mRNA replication resulting in uncontrolled toxic antigen production. All self-amplifying mRNA injections currently available for humans and animals should be IMMEDIATELY withdrawn.

The United States must REJECT this dangerous technology, especially with the FDA already approving a Phase 1 trial for a Gates-funded self-amplifying H5N1 “pandemic” bird flu injection:

 

See more here Thefocalpoints.com

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via